Elite Pharmaceuticals Inc (ELTP): Imagine what Nasrat might say during the...

Bngo · 2025-02-14T15:23:09.4770000Z

style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"Imagine what Nasrat might say during the conference call about future potential B/E studies with a few of these drugs style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px" 25 High-Valued Drugs Losing Patent Protection in 2025 style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px" style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px" https://biopharmaapac.com/analysis/60/5727/25-high-value-drugs-losing-patent-protection-in-2025-what-it-means-for-healthcare.html#:~:text=The%20pharmaceutical%20industry%20is%20bracing%20for%20a%20transformative,25%20high-revenue%20drugs%20set%20to%20lose%20patent%20protection style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"